Rivaroxaban versus Warfarin in Nonvalvular Atrial Fibrillation - The New England Journal of Medicine - 2011
Brief Summary:
Among patients with nonvalvular atrial fibrillation, rivaroxaban is noninferior to warfarin in preventing stroke and systemic thromboembolism.Reference: http://www.ncbi.nlm.nih.gov/pubmed/21830957
Comments
Post a Comment
Drop your thoughts here, we would love to hear from you